Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis

Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc. News
Charles River Laboratories International, Inc. Quantitative Score

About Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company also provides contract vivarium operation services to biopharmaceutical clients. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Charles River Laboratories International, Inc. Earnings & Revenue
Charles River Laboratories International, Inc. Financials
Table Compare
Compare CRL metrics with: | |||
---|---|---|---|
Earnings & Growth | CRL | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | CRL | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | CRL | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | CRL | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Charles River Laboratories International, Inc. Income
Charles River Laboratories International, Inc. Balance Sheet
Charles River Laboratories International, Inc. Cash Flow
Charles River Laboratories International, Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
Metrics | Score |
---|---|
Discounted Cash Flows | Buy |
Return on Equity | Neutral |
Return on Assets | Buy |
Debt/Equity Ratio | Strong Sell |
Price/Earnings Ratio | Strong Sell |
Price/Book Ratio | Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Charles River Laboratories International, Inc. Valuation
Project future cash flows and get the intrinsic value per share.
Historical Market Cap
Shares Outstanding
Charles River Laboratories International, Inc. Executives
Name | Role |
---|---|
Mr. James C. Foster J.D. | Chief Executive Officer, President & Chairman |
Ms. Flavia H. Pease | Corporate Executive Vice President & Chief Financial Officer |
Ms. Birgit Girshick | Corporate Executive Vice President & Chief Operating Officer |
Mr. Joseph W. LaPlume J.D. | Corporate Executive Vice President of Corporate Development & Strategy |
Mr. Todd Spencer | Corporate Vice President of Investor Relations |
Name | Role | Gender | Date of Birth | Pay |
---|---|---|---|---|
Mr. James C. Foster J.D. | Chief Executive Officer, President & Chairman | Male | 1951 | 2.66M |
Ms. Flavia H. Pease | Corporate Executive Vice President & Chief Financial Officer | Female | 1973 | 1.66M |
Ms. Birgit Girshick | Corporate Executive Vice President & Chief Operating Officer | Female | 1970 | 1.28M |
Mr. Joseph W. LaPlume J.D. | Corporate Executive Vice President of Corporate Development & Strategy | Male | 1974 | 928.36K |
Mr. Todd Spencer | Corporate Vice President of Investor Relations | Male | -- |
Charles River Laboratories International, Inc. Insider Trades
Date | 31 Jan |
Name | Pease Flavia |
Role | Corporate Executive VP & CFO |
Transaction | Acquired |
Type | A-Award |
Shares | 2704 |
Date | 31 Jan |
Name | Pease Flavia |
Role | Corporate Executive VP & CFO |
Transaction | Disposed |
Type | F-InKind |
Shares | 914 |
Date | 31 Jan |
Name | FOSTER JAMES C |
Role | Chairman, President and CEO |
Transaction | Acquired |
Type | A-Award |
Shares | 19608 |
Date | 31 Jan |
Name | FOSTER JAMES C |
Role | Chairman, President and CEO |
Transaction | Disposed |
Type | F-InKind |
Shares | 6827 |
Date | 31 Jan |
Name | LaPlume Joseph W |
Role | EVP, Corp Strategy & Develop |
Transaction | Acquired |
Type | A-Award |
Shares | 2738 |
Date | Name | Role | Transaction | Type | Shares |
---|---|---|---|---|---|
31 Jan | Pease Flavia | Corporate Executive VP & CFO | Acquired | A-Award | 2704 |
31 Jan | Pease Flavia | Corporate Executive VP & CFO | Disposed | F-InKind | 914 |
31 Jan | FOSTER JAMES C | Chairman, President and CEO | Acquired | A-Award | 19608 |
31 Jan | FOSTER JAMES C | Chairman, President and CEO | Disposed | F-InKind | 6827 |
31 Jan | LaPlume Joseph W | EVP, Corp Strategy & Develop | Acquired | A-Award | 2738 |